- Home
- MRNA vs DRS Comparison
MRNA vs DRS Comparison
Compare MRNA & DRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- DRS
- Stock Information
- Founded
- MRNA 2010
- DRS 1969
- Country
- MRNA United States
- DRS United States
- Employees
- MRNA N/A
- DRS N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- DRS Military/Government/Technical
- Sector
- MRNA Health Care
- DRS Industrials
- Exchange
- MRNA Nasdaq
- DRS Nasdaq
- Market Cap
- MRNA 10.9B
- DRS 11.0B
- IPO Year
- MRNA 2018
- DRS N/A
- Fundamental
- Price
- MRNA $24.47
- DRS $40.33
- Analyst Decision
- MRNA Hold
- DRS Strong Buy
- Analyst Count
- MRNA 19
- DRS 7
- Target Price
- MRNA $43.50
- DRS $46.43
- AVG Volume (30 Days)
- MRNA 9.9M
- DRS 873.0K
- Earning Date
- MRNA 11-06-2025
- DRS 10-29-2025
- Dividend Yield
- MRNA N/A
- DRS 0.89%
- EPS Growth
- MRNA N/A
- DRS 32.60
- EPS
- MRNA N/A
- DRS 0.94
- Revenue
- MRNA $3,078,000,000.00
- DRS $3,421,000,000.00
- Revenue This Year
- MRNA N/A
- DRS $11.94
- Revenue Next Year
- MRNA $10.17
- DRS $6.63
- P/E Ratio
- MRNA N/A
- DRS $42.98
- Revenue Growth
- MRNA N/A
- DRS 11.43
- 52 Week Low
- MRNA $23.15
- DRS $26.00
- 52 Week High
- MRNA $79.96
- DRS $49.31
- Technical
- Relative Strength Index (RSI)
- MRNA 38.50
- DRS 36.77
- Support Level
- MRNA $23.78
- DRS $40.24
- Resistance Level
- MRNA $25.48
- DRS $42.55
- Average True Range (ATR)
- MRNA 1.09
- DRS 0.99
- MACD
- MRNA 0.05
- DRS 0.03
- Stochastic Oscillator
- MRNA 25.00
- DRS 3.38
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About DRS Leonardo DRS Inc.
Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. The company is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.